CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
i
Respiratory Syncytial Virus (RSV) Preventive Antibody: Immunization Information Statement (IIS): What You Need to Know
-
09/25/2023
[PDF-163.24 KB]
Details:
-
Description:Current Edition Date: 9/25/2023
Why get immunized with a RSV preventive antibody?
A respiratory syncytial virus (RSV) preventive antibody can prevent severe lung disease caused by RSV.
RSV is a common respiratory virus that usually causes mild, cold-like symptoms but can also affect the lungs. Symptoms of RSV infection may include runny nose, decrease in appetite, coughing, sneezing, fever, or wheezing.
Anyone can become infected by RSV, and almost all children get an RSV infection by the time they are 2 years old. While most children recover from an RSV infection in a week or two, RSV infection can be dangerous for infants and some young children, causing difficulty breathing, low oxygen levels, and dehydration. In the United States, RSV is the most common cause of bronchiolitis (inflammation of the small airways in the lungs) and pneumonia (infection of the lungs) in children younger than 1 year of age. Children who get sick from RSV may need to be hospitalized, and some might even die.
Immunization-Information-Statement.pdf
-
Content Notes:Why get immunized with a RSV preventive antibody? -- RSV Preventive Antibodies -- Talk with your health care provider -- Risks of a reaction to RSV preventive antibodies -- What if there is a serious problem? -- How can I learn more?
-
Subjects:
-
Series:
-
Document Type:
-
Genre:
-
Pages in Document:2 unnumbered pages
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
